A Nomogram for Preoperative Prediction of Tumor Aggressiveness and Lymphovascular Space Involvement in Patients with Endometrial Cancer
Authors:
- Riccardo VallettaRVRiccardo Valletta
- Giacomo AvesaniGAGiacomo Avesani
- Vincenzo VingianiVVVincenzo Vingiani
- Bernardo PronerBPBernardo Proner
- Martin SteinkassererMSMartin Steinkasserer
- Sara NotaroSNSara Notaro
- Francesca VanzoFVFrancesca Vanzo
- Giovanni NegriGNGiovanni Negri
- Caterina VercelliCVCaterina Vercelli
- Matteo BonattiMatteo Bonatti
Preprint
- 24 April 2025
- preprint
- Published by MDPI AG in Preprints.org
Abstract
Background/Objectives: To develop a nomogram for predicting tumor aggressiveness and the presence of lymphovascular space involvement (LVSI) in patients with endo-metrial cancer (EC), using preoperative MRI and pathology-laboratory data. Methods: This IRB-approved, retrospective, multicenter study included 245 patients with histologically confirmed EC who underwent preoperative MRI and surgery at participating institutions between January 2020 and December 2024. Tumor type and grade, both from preoperative biopsy and surgical specimens, as well as preoperative CA125 and HE4 levels, were retrieved from institutional databases. Preoperative MRI was used to assess tumor morphology (polypoid vs. infiltrative), maximum diameter, presence and depth (< or >50%) of myometrial invasion, cervical stromal invasion (yes/no), and minimal tumor-to-serosa distance. The EC-to-uterus volume ratio was also calculated. Results: Among the 245 patients, 27% demonstrated substantial LVSI, and 35% were classified as aggressive on final histopathology. Multivariate analysis identified inde-pendent MRI predictors of LVSI, including cervical stromal invasion (OR = 9.06; p = 0.0002), tumor infiltration depth (OR = 2.09; p = 0.0391), and minimal tumor-to-serosa distance (OR = 0.81; p = 0.0028). The LVSI prediction model yielded an AUC of 0.834, with an overall accuracy of 78.4%, specificity of 92.2%, and sensitivity of 43.1%. For tumor aggressiveness prediction, significant predictors included biopsy grade (OR = 8.92; p < 0.0001), histological subtype (OR = 12.02; p = 0.0021), and MRI-detected serosal involvement (OR = 14.39; p = 0.0268). This model achieved an AUC of 0.932, with an accuracy of 87.0%, sensitivity of 79.8%, and specificity of 91.2%. Both models showed excellent calibration (Hosmer-Lemeshow p > 0.86). Conclusions: The integration of MRI-derived morphological and quantitative features with clinical and histopathological data allows for effective preoperative risk stratifica-tion in endometrial cancer. The two nomograms developed for predicting LVSI and tumor aggressiveness demonstrated high diagnostic performance and may support in-dividualized surgical planning and decision-making regarding adjuvant therapy. These models are practical, reproducible, and easily applicable in standard clinical settings without the need for radiomics software, representing a step toward more personalized gynecologic oncology.Keywords
All Related Versions
This publication has 31 references indexed in Scilit:
- Effect of coexisting adenomyosis on tumour characteristics and prognosis of endometrial cancer: A systematic review and meta-analysisTaiwanese Journal of Obstetrics and Gynecology, 2023
- FIGO staging of endometrial cancer: 2023International Journal of Gynecology & Obstetrics, 2023
- Endometrioid adenocarcinoma: combined multiparametric MRI and tumour marker HE4 to evaluate tumour grade and lymphovascular space invasionClinical Radiology, 2023
- CA125 as a predictor of endometrial cancer lymphovascular space invasion and lymph node metastasis for risk stratification in the preoperative settingScientific Reports, 2022
- Multiparametric MRI‐Based Radiomics Nomogram for Predicting Lymphovascular Space Invasion in Endometrial CarcinomaJournal of Magnetic Resonance Imaging, 2020
- LVSI positive and NX in early endometrial cancer: Surgical restaging (and no further treatment if N0), or adjuvant ERT?Gynecologic Oncology, 2020
- Prediction of histological grade of endometrial cancer by means of MRIEuropean Journal of Radiology, 2018
- Preoperative MR imaging for ESMO-ESGO-ESTRO classification of endometrial cancerDiagnostic and Interventional Imaging, 2018
- MRI for local staging of endometrial carcinoma: Is endovenous contrast medium administration still needed?European Journal of Radiology, 2015
- Lymphovascular space invasion is an independent risk factor for nodal disease and poor outcomes in endometrioid endometrial cancerGynecologic Oncology, 2012